Despite the widespread popularity of new weight-loss medications, research suggests a non-drug alternative is significantly ...

Researchers analysed 48 previously-conducted trials which examined the safety and efficacy of GLP-1 drugs on people with type ...

Eli Lilly said on Thursday its next-generation obesity drug helped patients lose an average of 28.7% of their weight in a ...

Discover why Eli Lilly and Company's retatrutide weight loss breakthrough positions LLY as a leader in obesity therapeutics.

Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...

GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...

Proteins, peptides, and pills, oh my! In 2025, NFL players, silver screen superheroes, and creators told us all about ...

SkinnyRx specializes in personalized weight loss treatment via telehealth. It provides access to glucagon-like peptide-1 (GLP-1) medications like semaglutide and tirzepatide. Its licensed, ...

Retatrutide is an investigational triple agonist developed by Eli Lilly that targets GLP-1, GIP and glucagon receptors, and ...